Pharma has become the EU’s most valuable high-tech export, driving the bloc’s first trade surplus in years. But can it survive the impact of US tariffs?
Pharma has become the EU’s most valuable high-tech export, driving the bloc’s first trade surplus in years. But can it survive the impact of US tariffs?